Max O Meneveau
7PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 12, 2022
The vaccine-site microenvironment: impacts of antigen, adjuvant, and same-site vaccination on antigen presentation and immune signaling.Max O Meneveau, Pankaj Kumar, Kevin T Lynch
|May 26, 2021
Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist.Max O Meneveau, Gina R Petroni, Elise P Salerno
|May 23, 2021
Correction to: Effects of Adjuvant Endocrine Therapy Adherence and Radiation on Recurrence and Survival Among Older Women with Early-Stage Breast Cancer.Shayna L Showalter, Max O Meneveau, Jessica Keim-Malpass
|May 13, 2021
Effects of Adjuvant Endocrine Therapy Adherence and Radiation on Recurrence and Survival Among Older Women with Early-Stage Breast Cancer.Shayna L Showalter, Max O Meneveau, Jessica Keim-Malpass
|Sep 13, 2020
Predicting adjuvant endocrine therapy initiation and adherence among older women with early-stage breast cancer.Max O Meneveau, Jessica Keim-Malpass, T Fabian Camacho
|May 01, 2020
Incomplete Freund's adjuvant reduces arginase and enhances Th1 dominance, TLR signaling and CD40 ligand expression in the vaccine site microenvironment.Karlyn E Pollack, Max O Meneveau, Marit M Melssen
Pageof 2
